Valsartan-hctz 320-25 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB26FABS7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,529
Award facts
- Contract value 100% obligated
- $1,529.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Valsartan-HCTZ 320-25 mg tablets (90-count unit) with a ceiling value of $1,529.49. The contract is a firm fixed-price, non-competitive set-aside award with an ultimate completion date of November 10, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1.0 billion through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency, operating under the Department of Defense, utilizes such pharmaceutical supply contracts to ensure critical medications reach military personnel, veterans, and other federal healthcare beneficiaries. This particular delivery order for the blood pressure medication represents routine procurement activity under AmerisourceBergen's existing prime vendor agreement, which has demonstrated the company's capability to meet federal medical supply requirements across multiple therapeutic domains and geographic regions. The firm fixed-price structure and non-set-aside designation reflect the competitive nature of pharmaceutical procurement within the DLA's supply chain operations.
Quick answers
Who was awarded contract SPE2DB26FABS7?
SPE2DB26FABS7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FABS7 worth?
The government has obligated $1,529 on SPE2DB26FABS7.
Is contract SPE2DB26FABS7 an order under another contract?
Yes. SPE2DB26FABS7 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABS7 competed?
The extent of competition for SPE2DB26FABS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award